subscribeSubscribe
NICE recommends Takeda’s Ninlaro triplet regimen

NICE recommends Takeda’s Ninlaro triplet regimen
PHARMATIMES
20 Jan 2023
Share Share
Takeda scores a win for Ninlaro

Takeda scores a win for Ninlaro
A. Weintraub FIERCE PHARMA
08 Nov 2019
Share Share
Declaring topline PhIII win, Takeda revives blockbuster hopes for its troubled multiple myeloma drug

Declaring topline PhIII win, Takeda revives blockbuster hopes for its troubled multiple myeloma drug
BUSINESSWIRE
08 Nov 2019
Share Share
Takeda sets December deadline for U.S. employees` Boston move

Takeda sets December deadline for U.S. employees` Boston move
K. Blankenship FIERCE PHARMA
27 Jun 2019
Share Share
Takeda swings and misses with Ninlaro in AL amyloidosis, calls off phase 3 trial

Takeda swings and misses with Ninlaro in AL amyloidosis, calls off phase 3 trial
Eric Sagonowsky FIERCE PHARMA
07 Jun 2019
Share Share
Takeda suffers another setback in its quest to expand myeloma drug’s reach

Takeda suffers another setback in its quest to expand myeloma drug’s reach
John Carroll ENDPTS
06 Jun 2019
Share Share
J&J eyes Darzalex convenience, safety boost with subcutaneous win

J&J eyes Darzalex convenience, safety boost with subcutaneous win
Carly Helfand FIERCE PHARMA
05 Jun 2019
Share Share
Takeda`s Ninlaro (ixazomib citrate) Receives Conditional approval in Europe

Takeda`s Ninlaro (ixazomib citrate) Receives Conditional approval in Europe
EMA
20 Oct 2018
Share Share
Takeda can`t sway NICE on oral myeloma therapy Ninlaro

Takeda can`t sway NICE on oral myeloma therapy Ninlaro
Phil Taylor PMLIVE
07 Sep 2017
Share Share
Chinese courts call for death penalty for researchers who commit fraud

Chinese courts call for death penalty for researchers who commit fraud
Ivan Oransky STATNEWS
23 Jun 2017
Share Share